Noah P. Tu

3,5-Bis(trifluoromethyl)pyrazoles:  A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djurić, Nwe Y. BaMaung, Anwer Basha et al. · Journal of Medicinal Chemistry · 2000 · 120 citations

Molecular Regulation, Immunology, Pharmacotherapy +18

High‐Throughput Reaction Screening with Nanomoles of Solid Reagents Coated on Glass Beads

Noah P. Tu, Amanda W. Dombrowski, Gashaw M. Goshu et al. · Angewandte Chemie International Edition · 2019 · 85 citations

Nanoparticles, Nanomedicine, Chemical Engineering +15

Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes

Peer B. Jacobson, Thomas W von Geldern, Lars Öhman et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 77 citations · Full text

Integrated Platform for Expedited Synthesis–Purification–Testing of Small Molecule Libraries

Aleksandra Baranczak, Noah P. Tu, Jasmina Marjanovic et al. · ACS Medicinal Chemistry Letters · 2017 · 74 citations · Full text

Combinatorial Chemistry, Bioorganic Chemistry, Polycomb Protein Eed +17

Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes

Thomas W von Geldern, Noah P. Tu, Philip R. Kym et al. · Journal of Medicinal Chemistry · 2004 · 71 citations · Full text

Immunology, Glucocorticoid, Metabolic Syndrome +16